Translation of "sos testing " (English → French) :

(c)coordinating the application by the national reference laboratories and, if necessary, by other official laboratories of the methods referred to in point (a), in particular, by organising regular inter-laboratory comparative testing or proficiency tests and by ensuring appropriate follow-up of such comparative testing or proficiency tests in accordance, where available, with internationally accepted protocols, and informing the Commission and the Member States of the results and follow-up to the inter-laboratory comparative testing or proficiency test ...[+++]s.

(Return tabled) Question No. 199 Ms. Kirsty Duncan: With regard to the development and operation of the Canadian Multiple Sclerosis Monitoring System (CMSMS) announced in March 2011: (a) what are the government's baseline assumptions for the CMSMS, (i) how many Canadians live with MS according to the government’s source, (ii) what is the government's source; (b) what have been the challenges in developing the system between March 2011 and today, (i) how has each challenge been overcome, (ii) what are the achievements to date, (iii) what milestones has the government planned between December 2013 and December 2015 and by what dates; (c) what is the cost of develo ...[+++]ping the system, broken down by costs to date; (d) how much money did the Canadian Institutes for Health Research (CIHR) contribute to the development of the CMSMS, (i) were there any other partners involved in the development of the system, (ii) if so, who are they, (iii) what has each contributed; (e) who was involved in the design and development of the CMSMS, (i) from what departments/institutions were they, (ii) were potential conflicts of interest declared and, if so, how; (f) what health information does the CMSMS track, specifically, with regard to (i) chronic cerebrospinal venous insufficiency (CCSVI), (ii) impacts of CCSVI treatment, including but not limited to use of the following scales, Expanded Disability Status Scale, Modified Fatigue Impact Scale, Multiple Sclerosis Impact Scale, and Multiple Sclerosis Quality of Life Inventory, (iii) pharmaceutical treatments for MS, (vi) adverse drug reactions by MS drug; (g) who is/was overseeing pilot testing, (i) who is/was responsible for ensuring that patient information is/was protected, (ii) who is/was responsible for the integrity of the results; (h) were ethical reviews for pilot testing necessary and, if so, on what date did each pilot site pass ethical review; (i) when is pilot testing expected to/did it take place and at which MS clinics ...

Test Method: Following are the test steps for measuring the true power requirements of the test unit in On Mode/Active Power, Sleep Mode/Low Power, and Off Mode/Standby Power. Manufacturers are required to test their computer monitors using the analogue interface, except in those cases where one is not provided (i.e., digital interface monitors, which are defined as only having a digital interface for purposes of this test method). For digital interface monitors, please see Footnote 8 for voltage information and then follow the test method below using a digital signal generator.

[Text] Question No. 208 Mr. Loyola Hearn: With regard to the use of chemical agents by the Canadian military, were chemical agents tested by the Canadian military and, if so: (a) in what year(s); (b) which chemical agents were tested; (c) where were chemical agents tested; (d) were there different locations where chemical agents were stored and not tested; (e) were there chemical agents tested or stored at CFB Shilo and posted to CFB Petawawa and, if so, what type of tests were performed and how often; (f) what quantity of agents were stored at CFB Shilo and CFB Petawawa respectively and for how long; (g) were there ongoing shipments of chemical agents from base to base; (h) were military personnel made aware when they were involved ...[+++]in the transport or storage of chemical agents; (i) was there a safety policy relative to chemical agents at the time of storage or testing; (j) how many times has the safety regulations protocol pertaining to chemical agents been amended since the 1960s; and (k) does the current policy differ greatly from military policies of the 1960s, 1970s, 1980s, and 1990s and, if so, in which way?

Surfactants shall be considered as readily biodegradable if the level of biodegradability (mineralisation) measured according to one of the five following tests is at least 60 % within 28 days: CO headspace test (OECD 310), carbon dioxide (CO) evolution modified Sturm test (OECD 301B; Council Directive 67/548/EEC Annex V. C.4-C), closed bottle test (OECD 301D; Directive 67/548/EEC Annex V.C.4-E), manometric respirometry (OECD 301F; Directive 67/548/EEC Annex V.C.4-D), or MITI (I) test (OECD 301C; Directive 67/548/EEC Annex V.C.4-F), or their equivalent ISO tests.

(i) description of the control testing methods employed by the manufacturer (qualitative and quantitative analysis of the constituents and the finished product, specific tests e.g. sterility tests, test for the presence of pyrogens, for the presence of heavy metals, stability tests, biological and toxicity tests, tests on intermediate products).